Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.40 |
| ▸ | HPGD | P15428 | 3/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 5/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.40 |
| ▸ | MAPT | P10636 | 5/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.40 |
| ▸ | FTO | Q9C0B1 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | USP2 | O75604 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | RECQL | P46063 | 1/20 | 0.40 |
| ▸ | BLM | P54132 | 1/20 | 0.40 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.40 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.40 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.40 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8757874 | 0.88 | FTO (0.41) | CYP3A4ALDH1A1HPGDHSD17B10MEN1 | |
| SCHEMBL5532838 | 0.85 | NPC1 (0.44) | CYP3A4ALDH1A1HPGDHSD17B10KDM4E | |
| SCHEMBL10709421 | 0.84 | CYP3A4 (0.41) | CYP3A4ALDH1A1HPGDHSD17B10MEN1 | |
| SCHEMBL11666220 | 0.84 | FTO (0.59) | CYP3A4ALDH1A1HPGDHSD17B10MEN1 | |
| SCHEMBL1524853 | 0.81 | PRKCA (0.47) | CYP3A4ALDH1A1MEN1KMT2AMAPT | |
| SCHEMBL10358710 | 0.81 | CYP3A4 (0.45) | CYP3A4ALDH1A1HPGDHSD17B10KDM4E | |
| SCHEMBL15141720 | 0.81 | INPPL1 (0.41) | CYP3A4ALDH1A1HPGDHSD17B10KDM4E | |
| SCHEMBL1603421 | 0.80 | MAPT (0.42) | CYP3A4ALDH1A1HPGDHSD17B10MEN1 | |
| SCHEMBL9557864 | 0.80 | ALDH1A1 (0.38) | CYP3A4ALDH1A1HPGDHSD17B10KDM4E | |
| SCHEMBL9712154 | 0.78 | ALDH1A1 (0.36) | CYP3A4ALDH1A1HPGDHSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 357 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070119450-A1 | Medication holder | TIANDA PHARMACEUTICALS (AUSTRALIA) PTY LIMITED (AU) | 2007-05-31 | — | — | US | claimed |
| EP-1675636-A1 | MEDICATION HOLDER | Medi-Stream Pty Ltd. (AU) | 2006-07-05 | — | — | EP | claimed |
| WO-2005028006-A1 | MEDICATION HOLDER | MEDI-STREAM PTY LTD (AU) | 2005-03-31 | — | — | WO | claimed |
| EP-1073425-A1 | FIBRINOGEN COATED DROPLETS OF LIQUID HYDROPHOBIC PHASES | THE UNIVERSITY OF CINCINNATI (US) | 2001-02-07 | — | — | EP | claimed |
| WO-1999055314-A1 | FIBRINOGEN COATED DROPLETS OF LIQUID HYDROPHOBIC PHASES | UNIVERSITY OF CINCINNATI (US) | 1999-11-04 | — | — | WO | claimed |
| US-5560933-A | INCLUDES BIOCOMPATIBLE POLYMER CAPABLE OF BEING CROSSLINKED BY DISULFIDE BONDS TO PRODUCE SHELL | VIVORX PHARMACEUTICALS, INC. (US) | 1996-10-01 | — | — | US | claimed |
| US-5439686-A | Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor | VIVORX PHARMACEUTICALS, INC. (US) | 1995-08-08 | — | — | US | claimed |
| US-4399686-A | FOR ANAESTHETICS, SUBSTRATE COATED WITH SILICONE GLYCOL COPOLYMER | ENGSTROM MEDICAL AB (SE) | 1983-08-23 | — | — | US | claimed |
| EP-4740953-A1 | PHARMACEUTICAL COMPOSITION COMPRISING CO2 FOR USE IN THE TREATMENT OF CONDITIONS ASSOCIATED WITH HEADACHE | Migrainy UG (haftungsbeschränkt) (DE) | 2026-05-13 | — | — | EP | disclosed |
| WO-2026087643-A1 | COMPOSITION AND DEVICE COMPRISING CO2 FOR THERAPEUTIC USES | MIGRAINY UG (DE) | 2026-04-30 | — | — | WO | disclosed |
| US-12378301-B2 | B1SP fusion protein therapeutics, methods, and uses | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2025-08-05 | — | — | US | disclosed |
| US-RE49758-E1 | Stabilised protein compositions based on semifluorinated alkanes | NOVALIQ GMBH (DE) | 2023-12-19 | — | — | US | disclosed |
| EP-3313526-B1 | B1SP FUSION PROTEIN THERAPEUTICS, METHODS, AND USES | UNIV BRITISH COLUMBIA (CA) | 2023-11-08 | — | — | EP | disclosed |
| CN-115671084-B | Application of methoxyflurane in preparation of medicines for resisting echinococcosis | 四川大学华西医院 | 2023-09-15 | — | — | CN | disclosed |
| US-4172709-A | Bacteria filters with transparent housings | BECTON, DICKINSON AND COMPANY (US) | 1979-10-30 | — | — | US | disclosed |
| US-4171962-A | Bacteria filters with transparent housings | BECTON, DICKINSON AND COMPANY (US) | 1979-10-23 | — | — | US | disclosed |
| US-4133656-A | Bacteria filters with transparent housings | BECTON, DICKINSON AND COMPANY (US) | 1979-01-09 | — | — | US | disclosed |
| US-4063913-A | Bacteria filters with transparent housings | BECTON, DICKINSON AND COMPANY (US) | 1977-12-20 | — | — | US | disclosed |
| US-4058120-A | Vaporizer carousel for anesthesia machine | AIR PRODUCTS AND CHEMICALS, INC. (US) | 1977-11-15 | — | — | US | disclosed |
| US-3954893-A | INHALATION ANESTHETICS | W. R. GRACE & CO. (US) | 1976-05-04 | — | — | US | disclosed |